Read ePaper

CERVAVAC

Vaccines for cervical cancer prevention will be available in large quantities from 2024, says SII CEO Adar Poonawalla

25 Jan 2023

Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday said that the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine availability will be little in number this year and will be increased in 2024. Talking to the media SII CEO said, "I had come to brief the...

Production of HPV vaccine to start in 2023: Adar Poonawala

21 Oct 2022

The Serum Institute of India will start the production of India's first indigenously developed quadrivalent Human Papillomavirus (HPV) "CERVAVAC" vaccine, for the prevention of cervical cancer in the first quarter of 2023. Due to the COVID-19 pandemic, the production of vaccines got delayed. "The capacity got delayed by one year...